INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE
A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis
EuroIntervention 2016;12:e1413-e1419 published online e-edition December 2016. DOI: 10.4244/EIJ-D-15-00511
Christoph K. Naber1*, MD; Stylianos A. Pyxaras1, MD; Hüseyin Ince2,3, MD; Peter Frambach4, MD; Antonio Colombo5, MD; Christian Butter6, MD; Fernando Gatto7, MD; Ulrich Hink8, MD; Georg Nickenig9, MD; Giuseppe Bruschi10, MD; Guus Brueren11, MD; Didier Tchétché12, MD; Peter Den Heijer13, MD; Wolfgang Schillinger14, MD; Smita Scholtz15, MD; Jan Van der Heyden16, MD, PhD; Thierry Lefèvre17, MD; Martine Gilard18, MD; Karl-Heinz Kuck19
1. Contilia Heart and Vascular Centre, Elisabeth-Krankenhaus Essen, Essen, Germany; 2. Vivantes Klinikum im Friedrichshain und Am Urban, Berlin, Germany; 3. Universitätsklinikum Rostock, Rostock, Germany; 4. Institut de Chirurgie Cardiaque et de Cardiolog
Aims: Our aim was to assess the clinical outcomes of the Direct Flow Medical Transcatheter Aortic Valve System (DFM-TAVS), when used in routine clinical practice.